Antibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection. Issue 1 (15th June 2022)

• Record Type: Journal Article
• Authors: Bosserman, Rachel E.; Farnsworth, Christopher W.; O'Neil, Caroline A.; Cass, Candice; Park, Daniel; Ballman, Claire; Wallace, Meghan A.; Struttmann, Emily; Stewart, Henry; Arter, Olivia; Peacock, Kate; Fraser, Victoria J.; Budge, Philip J.; Olsen, Margaret A.; Burnham, Carey-Ann D.; Babcock, Hilary M.; Kwon, Jennie H.
• Other Names: collab.
• Is Part Of: Antimicrobial stewardship & healthcare epidemiology. Volume 2:Issue 1(2022)
• Publication Date: 2022-06-15
• Subjects: Anti-infective agents -- Periodicals; Nosocomial infections -- Prevention -- Periodicals; Epidemiology -- Periodicals; 614.44
• DOI: 10.1017/ash.2022.231
• Languages: English
• ISSNs: 2732-494X

Abstract

Abstract: In a prospective cohort of healthcare personnel (HCP), we measured severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) nucleocapsid IgG antibodies after SARS-CoV-2 infection. Among 79 HCP, 68 (86%) were seropositive 14–28 days after their positive PCR test, and 54 (77%) of 70 were seropositive at the 70–180-day follow-up. Many seropositive HCP (95%) experienced an antibody decline by the second visit.